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This article aims to question the utility of current surgical
methods and their alternatives for the treatment of world-
threatening “diabesity” pandemic. We, as surgeons, need to
address the following question honestly—“Are we offering
the best surgical procedure to our patients?”
Despite the evidence suggestive of inadequate and disappoint-
ing results with restrictive techniques like vertical banded
gastroplasty (VBG) and gastric banding, why is the surgical
fraternity still performing restrictive operations and trying to
revise the restrictive or combination operations (i.e., gastric
bypass) with further restriction?
It is quite unfortunate to note the growing number of
revision operations performed by bariatric and metabolic sur-
geons. Apparently, any restriction on humans seems to fail
eventually, as observed with mechanical restrictive operations
done for the surgical treatment of obesity. Therefore, we wish
to highlight the potential surgical use of ileal anorexigenic
neuropeptides (i.e., GLP-1, PYY, and oxyntomodulin) for the
treatment of metabolic syndrome and related co-morbidities.
From this perspective, it is plausible to take a short look at
the physiology of hunger and satiety. After ingesting a portion
of a meal, the food is sent to the gut for digestion. Hunger is a
vital primitive instinct, which is not resolved in the stomach,
but in the gut. Only when food reaches the ileum does signals
of satiety are released, gastric emptying slows down, and a
feeling of fullness coincides. Thus, satisfaction occurs only
after eating a considerable amount of food and not after the
first bite. However, restrictions like a band, pouch, narrow
anastomosis, or a tube, limit ingestion and are unable to
provide a marked intestinal satiety as a natural consequence
of the abovementioned physiological process. Mechanical
restriction represents a static obstacle for the passage of food
after each ingestion step, and is clearly counterintuitive from a
physiological viewpoint [1]. On the other hand, ileal
proximalization and activation of the ileal peptides may bring
forth a type of “functional restriction” and “metabolic satiety”
that limit the stocking, not ingestion.
Metabolic surgery should stay away from mechanical re-
striction and target a functional restriction. The only possible
way to accomplish this is to activate the ileal anorexigenic
neuropeptides in the early course of digestion. If the intestinal
satiety signals are too weak or come late during digestion, it
would be possible for an individual to consume greater
amounts of food before the emergence of metabolic satiety.
Malabsorptive operations, particularly biliopancreatic di-
version (BPD) and duodenal switch (DS), do have the capa-
bility to induce the release of these peptides, since the whole
jejunum is bypassed, and the gastro–ileal or duodeno–ileal
anastomosis deliver food directly into ileum. However, these
operations have a price to pay in the form of malabsorption
and nutritional deficiencies. On the other hand, “functional
restriction” through surgical ileal proximalization offers a
chance to release the aforementioned peptides without causing
significant malabsorption. These peptides not only induce
satiety, but also improve the insulinemic responses, suppress
the activity and release of glucagon, and decrease endogenous
glucose production and free fatty acid release.
Two major issues should be addressed though. Firstly, how
can it be possible to obtain surgical ileal proximalization
without causing significant malabsorption, and secondly, what
is the significance of the presence of malabsorption after
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bariatric and metabolic surgical techniques? With regard
to the latter, it is very important to realize that malab-
sorption itself is a disease. We all have to question the
extent of the consequences of our actions on our pa-
tients in a responsible manner, since this strategy is
associated with the risk of terminating of one type of
addiction while triggering another. Therefore, efforts should
be paid to seek for alternatives of ileal proximalization without
significant malabsorption.
There are two possible published surgical options that can
provide a functional restriction without significant malabsorp-
tion. These are transit bipartition (TB) and ileal transposition
(IT) (Fig. 1, [1, 2]).
Both operations are performed laparoscopically together with
a sleeve gastrectomy in order to reduce ghrelin levels, avoid
peptic ulcers, decrease the caloric intake, and avoid a gastric
dilation [1]. However, these techniques use different strategies.
IT maximizes distal gut activity by interposing a segment of
ileum right after the stomach andminimizes proximal activity by
excluding the duodenum [3, 4]. TB enhances distal activity
by bringing the whole ileum to the antrum and dimin-
ishes proximal activity by shifting food from the duo-
denal route, which is left intact; what further minimizes
malabsorption (and amplifies endoscopic access, instead
of reducing it). Both procedures aim at functional (and
not the mechanical) restriction, trying to avoid malabsorption,
instead of having it as a beneficial goal.
In conclusion, bariatric and metabolic surgery is still evolv-
ing and there will always be a search for better surgical
techniques. Novel surgical methods can potentially provide
more physiological solutions both for our patients and for us
as surgeons, in our battle against the pandemic of obesity
and diabetes. But, that should not refrain us from questioning
the appropriateness of restriction andmalabsorption, andmax-
imum effort should bemade to avoid treating one condition by
replacing it with a new one.
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